August Troendle

Early Life and Education

August J. Troendle, M.D., was born on January 1, 1956. He earned his Medical Degree from the University of Maryland, School of Medicine and his Master of Business Administration from Boston University.

Rise to Success

Dr. Troendle's career began with a focus on pharmaceutical development. Before founding Medpace, he held positions at Sandoz (now Novartis), where he was responsible for the clinical development of lipid-altering agents. He also worked as a Medical Review Officer in the Division of Metabolic and Endocrine Drug Products at the FDA from 1986 to 1987. In 1992, Dr. Troendle founded Medpace, a full-service CRO, with the vision of offering a more innovative approach to clinical trials.

Key Business Strategies

Medpace, under Dr. Troendle's leadership, has become a pre-eminent CRO, providing services to sponsors in drug and device development across over 45 countries. The company focuses on physician-led clinical development and internal expertise to ensure high-quality research. The company's mission is to accelerate the global development of safe and effective medical therapeutics.

Philanthropy

Specific philanthropy amounts could not be located in the search results, but Dr. Troendle's recognition as the EY Entrepreneur Of The Year suggests community involvement. Further research may reveal specific initiatives.